The Australian Government is investing $10 million in a take home naloxone (THN) pilot in New South Wales, South Australia and Western Australia. From 1 December, community (s90) pharmacies have been able to claim for reimbursement for supplies of naloxone to individuals under the THN pilot. From today, hospital (s94) pharmacies and approved medical practitioners (s92) will also be able to claim for reimbursement for supplies of naloxone to individuals.
Approved Alternative Suppliers in these states will also now be able to report any supplies of naloxone they make under the THN pilot, via the PPA portal.
More information about program registration and claiming can be found here.